Limbas, Rotchel P.
HRN: 06-38-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFUROXIME 500MG (TAB)
06/14/2022
06/20/2022
PO
500mg
BID
S/p Hysterectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes